CanSino Biologics, Inc. Class H's total assets for Q4 2024 were ¥0.00, a decrease of -100.00% from the previous quarter. HK:6185 total liabilities were ¥-5.06B for the fiscal quarter, a -273.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.